Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
29.82
-0.03 (-0.10%)
Apr 21, 2026, 3:00 PM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
246.61224.16362.07269.23254.37
Trading Asset Securities
2.617.5090200
Cash & Short-Term Investments
249.21241.66362.07359.23454.37
Cash Growth
3.12%-33.26%0.79%-20.94%298.63%
Accounts Receivable
655.97570.35491.55491.69342.52
Other Receivables
2.5811.13.781.1
Receivables
658.55571.35492.65495.48343.62
Inventory
62.3885.6872.1278.5274.5
Prepaid Expenses
1.05-000.06
Other Current Assets
25.149.454.352.662.42
Total Current Assets
996.33908.14931.19935.89874.98
Property, Plant & Equipment
630.67572.3425.87378.35259.27
Other Intangible Assets
16.916.3316.8217.5113.78
Long-Term Deferred Tax Assets
24.9118.2114.079.567.11
Long-Term Deferred Charges
354.04291.5195.76132.3134.93
Other Long-Term Assets
0.220.5628.895.2421.82
Total Assets
2,0231,8071,6131,4791,212
Accounts Payable
153.0786.2940.0680.6834.28
Accrued Expenses
465.14368.06346.13321.65251.98
Short-Term Debt
3024.224.28535
Current Portion of Long-Term Debt
68.8287.4231.6910-
Current Portion of Leases
3.24----
Current Income Taxes Payable
-9.443.749.464.03
Current Unearned Revenue
0.990.513.626.717.5
Other Current Liabilities
15.8319.6726.7911.738.88
Total Current Liabilities
737.07595.59476.22525.23341.66
Long-Term Debt
323.72249.53177.2929.99-
Long-Term Leases
7.260.644.439.043.25
Long-Term Unearned Revenue
29.1624.7919.9820.1118.67
Long-Term Deferred Tax Liabilities
8.392.462.722.562.3
Other Long-Term Liabilities
13.480.531.210.091.33
Total Liabilities
1,119873.54681.84587.02367.22
Common Stock
405.71405.93406.16405.27405.27
Additional Paid-In Capital
560.58606605.75580.95570.56
Retained Earnings
-59.44-81.7-87.04-104.59-131.17
Treasury Stock
-3.17-5.56-7.96--
Total Common Equity
903.68924.68916.91881.63844.66
Minority Interest
0.38.8213.8610.22-
Shareholders' Equity
903.98933.5930.77891.85844.66
Total Liabilities & Equity
2,0231,8071,6131,4791,212
Total Debt
433.03361.79237.61134.0338.25
Net Cash (Debt)
-183.82-120.13124.47225.2416.11
Net Cash Growth
---44.73%-45.88%381.08%
Net Cash Per Share
-0.45-0.300.310.561.08
Filing Date Shares Outstanding
405.71405.93406.16405.27405.27
Total Common Shares Outstanding
405.71405.93406.16405.27405.27
Working Capital
259.26312.55454.97410.67533.31
Book Value Per Share
2.232.282.262.182.08
Tangible Book Value
886.78908.35900.08864.11830.88
Tangible Book Value Per Share
2.192.242.222.132.05
Buildings
224.69224.6996.22103.17103.17
Machinery
383.4318.26299.39261.88245.29
Construction In Progress
226.26211.27181.35135.4911.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.